Key result
Antithrombotic therapy for elderly DVT requires careful dose adjustments to balance thrombosis and bleeding risks.
Why the study?
Elderly people have a higher risk of DVT with multifactorial causes and challenges in diagnosis and anticoagulation management due to bleeding risk.
Managing DVT in the elderly requires careful consideration of atypical symptoms, age-related diagnostic challenges, and balancing thrombosis risk against an increased risk of bleeding complications with anticoagulants.
Answers are grounded in this paper and cite their sources.
Heightened DVT suspicion is warranted in elderly patients with atypical symptoms; leaves open whether age-specific diagnostic thresholds improve accuracy.
Elderly people have a higher risk of deep vein thrombosis (DVT) than younger adults. The causes of this are considered multifactorial, including changes in age-related hemostatic factors, greater comorbid conditions, and the frequency of hospitalizations, although they are not fully understood. Besides, DVT in the elderly can be difficult to recognize because the symptoms can appear atypically. The diagnostic approach of DVT remains the same for all age groups, including pre-test probability, D-dimer measurement, and imaging, although these can be less specific in older age. Antithrombotic agents are the main treatment of DVT. Direct oral anticoagulation (DOAC) provides clinicians with more choices for DVT therapy. However, the anticoagulation of DVT in the elderly must always be done carefully, because old age is also a risk factor for the occurrence of bleeding complications. Identifying bleeding risk factors that can be modified and balancing the risk of thrombosis with bleeding, including the selection and adjustment of anticoagulant doses, are important in considerations of using anticoagulants in the elderly. This narrative review summarizes the literature on the management of DVT in the elderly
No takes yet. Share an insight, caveat, or question.
Mulia et al. (2020) conducted a review in Deep vein thrombosis (DVT). Antithrombotic agents (including DOACs) was evaluated. Managing deep vein thrombosis in the elderly with antithrombotic agents requires careful balancing of thrombosis and bleeding risks, including appropriate dose adjustments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: